Clasificación en acciones
#12737
Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to... Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the glucocerebrosidase enzyme. Initially established as Integral Medicines, Inc., the company rebranded to Graphite Bio, Inc. in August 2020. Founded in 2017, Graphite Bio's operations are based out of its headquarters in South San Francisco, California.
Precio por acción
$22.26
Última sincronización: 2024-03-22
Capitalización bursátil
$553.40M
Comercio Graphite Bio, Inc. (GRPH)
Precio GRPH con Capital del mercado a B
Capitalización de mercado de Graphite Bio, Inc.(GRPH)
Capitalización bursátil: $553.40M
A fecha de August 2026, Graphite Bio, Inc. tiene una capitalización de mercado de $553.40M. Esto convierte a Graphite Bio, Inc. en la 12737th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Graphite Bio, Inc. desde 2021 hasta 2026
GRPH en comparación con los más populares 5 títulos stocks
| Precio por GRPH |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.264T
|
+951,087.60%
|
|
|
|
|
$4.701T
|
+849,426.54%
|
|
|
|
|
$4.177T
|
+754,721.34%
|
|
|
|
|
$3.817T
|
+689,709.24%
|
|
|
|
|
$2.866T
|
+517,850.72%
|
